2017
DOI: 10.1590/2359-3997000000283
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Objective: This cross sectional study intended to evaluate two bedside tests (Neuropad and VibraTip) as screening tools for distal symmetrical polyneuropathy (DSPN) in Latin American patients with type 2 diabetes mellitus (T2D). Subjects and methods: Ninety-three Colombian patients diagnosed with T2D were recruited. Anthropometric variables, glycemic control parameters, lipid profile and renal function were assessed for each patient. DSPN was defined by a Michigan Neuropathy Screening Instrument (MNSI) clinica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…In our sample, Neuropad™ was abnormal in the majority of participants with sudomotor dysfunction symptoms (63.1%) and documented DPN (52.6%). This suggests a combination of sudomotor dysfunction and DPN, reinforcing the association between DAN and DPN in this scenario of peripheral dysautonomic impairment [ 8 , 9 , 41 , 42 ].…”
Section: Discussionmentioning
confidence: 63%
See 1 more Smart Citation
“…In our sample, Neuropad™ was abnormal in the majority of participants with sudomotor dysfunction symptoms (63.1%) and documented DPN (52.6%). This suggests a combination of sudomotor dysfunction and DPN, reinforcing the association between DAN and DPN in this scenario of peripheral dysautonomic impairment [ 8 , 9 , 41 , 42 ].…”
Section: Discussionmentioning
confidence: 63%
“…In the study by Gómez-Banoy et al, 66.6% of patients with DPN presented an abnormal Neuropad™ result [ 41 ]. The study by Mendevil et al, also from Colombia, analyzed 154 patients with DM, showing that 67.5% had an abnormal Neuropad™ test, and higher neuropathic symptom scores (Michigan Neuropathy Disability Score – MNDS and Total Symptoms Score – TSS) were found in those with an abnormal test [ 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the combinations of MNSI and SUDOSCAN [ 88 , 89 ] or MNSI, Neuropad, and Vibratip have been used to rapidly and non-invasively detect diabetic peripheral neuropathy [ 90 ]. Overall, evidence from such studies and current guideline recommendations support the use of various combinations of assessments during screening for diabetic peripheral neuropathy.…”
Section: Resultsmentioning
confidence: 99%